These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29374574)

  • 1. Gabapentin reduces haloperidol-induced vacuous chewing movements in mice.
    Ceretta APC; de Freitas CM; Schaffer LF; Reinheimer JB; Dotto MM; de Moraes Reis E; Scussel R; Machado-de-Ávila RA; Fachinetto R
    Pharmacol Biochem Behav; 2018 Mar; 166():21-26. PubMed ID: 29374574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallels between behavioral and neurochemical variability in the rat vacuous chewing movement model of tardive dyskinesia.
    Bachus SE; Yang E; McCloskey SS; Minton JN
    Behav Brain Res; 2012 Jun; 231(2):323-36. PubMed ID: 22503783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
    Naidu PS; Kulkarni SK
    Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
    Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
    Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter.
    Fachinetto R; Villarinho JG; Wagner C; Pereira RP; Avila DS; Burger ME; Calixto JB; Rocha JB; Ferreira J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Oct; 31(7):1478-86. PubMed ID: 17669571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesia.
    Lister J; Andreazza AC; Navaid B; Wilson VS; Teo C; Nesarajah Y; Wilson AA; Nobrega JN; Fletcher PJ; Remington G
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jan; 72():23-29. PubMed ID: 27565433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
    Bordia T; Zhang D; Perez XA; Quik M
    Exp Neurol; 2016 Dec; 286():32-39. PubMed ID: 27658674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements.
    Sasaki T; Kennedy JL; Nobrega JN
    Psychopharmacology (Berl); 1996 Nov; 128(1):97-104. PubMed ID: 8944412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
    Turrone P; Remington G; Kapur S; Nobrega JN
    Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
    Marchese G; Casu MA; Bartholini F; Ruiu S; Saba P; Gessa GL; Pani L
    Eur J Neurosci; 2002 Apr; 15(7):1187-96. PubMed ID: 11982629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of EGb761 and vitamin E on haloperidol-induced vacuous chewing movements in rats: Possible involvement of S100B mechanisms.
    An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Lv MH; Zhou DF; Soares JC; Kosten TR; Yang FD; Zhang XY
    Behav Brain Res; 2016 Jan; 297():124-30. PubMed ID: 26455874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of antipsychotics on haloperidol-induced vacuous chewing movements and subcortical gene expression in the rat.
    McCullumsmith RE; Stincic TL; Agrawal SM; Meador-Woodruff JH
    Eur J Pharmacol; 2003 Sep; 477(2):101-12. PubMed ID: 14519413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.
    Turrone P; Remington G; Kapur S; Nobrega JN
    Neuropsychopharmacology; 2003 Aug; 28(8):1433-9. PubMed ID: 12838271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
    Bishnoi M; Chopra K; Kulkarni SK
    Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
    Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia.
    Hashimoto T; Ross DE; Gao XM; Medoff DR; Tamminga CA
    Psychopharmacology (Berl); 1998 May; 137(2):107-12. PubMed ID: 9629996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effect of neurosteroids in haloperidol-induced vacuous chewing movements and related behaviors.
    Bishnoi M; Chopra K; Kulkarni SK
    Psychopharmacology (Berl); 2008 Feb; 196(2):243-54. PubMed ID: 17955214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol.
    Meshul CK; Andreassen OA; Allen C; Jørgensen HA
    Psychopharmacology (Berl); 1996 Jun; 125(3):238-47. PubMed ID: 8815959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide attenuates haloperidol-induced vacuous chewing movements in rats.
    Röpke J; Busanello A; Leal CQ; de Moraes Reis E; de Freitas CM; Villarinho JG; Figueira FH; Mello CF; Ferreira J; Fachinetto R
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():195-9. PubMed ID: 24747871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.